H.R. 6321 · 119th Congress · Health

Lung Cancer Medicare Access to Precise Testing Act

In committee204 words Introduced Nov 28, 2025 · Latest action Nov 28, 2025

How far it has goneStage 2 of 6
  1. IntroducedNov 28, 2025 Done
  2. CommitteeReferred to 2 committees Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

Full text

No CRS summary yet · 204 words

H.R. 6321 · Introduced in House · Nov 28, 2025

SECTION 1. SHORT TITLE.

This Act may be cited as the Lung Cancer Medicare Access to Precise Testing Act .

SEC. 2. REQUIRING COVERAGE OF LUNG CANCER BIOMARKER TESTING UNDER MEDICARE.

(a) Coverage. Section 1861 of the Social Security Act ( 42 U.S.C. 1395x ) is amended— (1) in subsection (s)(2)— (A) in subparagraph (JJ), by adding and at the end; and (B) by adding at the end the following new subparagraph: (KK) lung cancer biomarker testing (as defined in subsection (nnn)); ; and (2) by adding at the end the following new subsection: (nnn) Lung cancer biomarker testing The term lung cancer biomarker testing means a test furnished on or after January 1, 2027, to an individual diagnosed with lung cancer for the identification of 1 or more specific biomarkers (such as genes, proteins, or other molecules) based on the analysis of such individual’s tissue, blood, or bodily fluids. .

(b) Payment. Section 1833(a)(1) of the Social Security Act ( 42 U.S.C. 1395y(a)(1) ) is amended— (1) by striking and (HH) and inserting (HH) ; and (2) by inserting , and (II) with respect to lung cancer biomarker testing (as defined in section 1861(nnn)), the amount paid shall be 100 percent of the reasonable charges for such testing before the semicolon at the end.

Shown here because the text is under 500 words. Open on Congress.gov

Who lobbies on it

1 organization · 2 filings · Q4 2025–Q3 2026

See which of this bill’s sponsors and cosponsors got money from Equifax, Inc’s PAC → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. Equifax, Inc 2 of 4 quarters
    “Issues related to the Work Opportunity Tax Credit, including H.R. 1177/S. 492 - Improve and Enhance the Work Opportunity Tax Credit Act and H.R. 6321/S. 3265 - Improve and Enhance the Work Opportunity Tax Credit Act.”

    $1.6M lobbying spend in 2026 to date, all issuesQ3 2026 filing

Organizations that named H.R. 6321 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

2 actions · newest first
  1. Nov 28, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  2. Nov 28, 2025Introduced in House